Total trials
55
Active
7
Phase 3
3
Total enrollment
8,991
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Stannous fluoride and Potassium nitrate Dentifrice | — | — | — | — | — | 1 | |
| Stannous fluoride Dentifrice | — | — | — | — | — | 1 | |
| Potassium nitrate Dentifrice | — | — | — | — | — | 1 | |
| Vehicle Dentifrice | — | — | — | — | — | 1 | |
| Test Product | — | — | — | — | — | 1 | |
| Test Dentifrice | — | — | — | — | 6 | ||
| Reference Dentifrice | — | — | — | — | 6 | ||
| Colgate Cavity Protection | — | — | — | — | — | 2 | |
| Parodontax Complete Protection | — | — | — | — | — | 1 |
Next readouts
- 2026-07
- 2026-08
- 2026-09
- 2026-10
Top conditions
- Dentin Sensitivity14
- Gingivitis10
- Pain7
- Dental Plaque7
- Sunscreening Agents5
- Denture Retention3
- Dentin Hypersensitivity3
- Oral Hygiene2
Frequently asked questions about HALEON
- How many clinical trials does HALEON have on ClinicalTrials.gov?
- HALEON is listed as the lead sponsor on 55 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of HALEON's trials are in Phase 3?
- 3 of HALEON's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does HALEON focus on?
- HALEON's most-studied conditions on ClinicalTrials.gov are Dentin Sensitivity, Gingivitis, Pain, Dental Plaque, Sunscreening Agents.
- When are HALEON's next clinical trial readouts?
- HALEON has 4 upcoming primary-completion readouts tracked here; the soonest is “A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation”, expected around 2026-07.